Barclays
NUVL

Barclays’s Nuvalent NUVL Stock Holding History

Barclays’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.16M Sell
30,844
-94,484
-75% -$9.63M ﹤0.01% 2094
2025
Q4 		$12.6M Sell
125,328
-1,552
-1% -$153K ﹤0.01% 1517
2025
Q3 		$11M Sell
126,880
-22,726
-15% -$1.8M ﹤0.01% 1599
2025
Q2 		$11.4M Buy
149,606
+53,569
+56% +$3.92M ﹤0.01% 1483
2025
Q1 		$6.81M Sell
96,037
-2,084
-2% -$163K ﹤0.01% 1680
2024
Q4 		$7.68M Buy
98,121
+30,014
+44% +$2.8M ﹤0.01% 1784
2024
Q3 		$6.97M Buy
68,107
+40,754
+149% +$3.38M ﹤0.01% 1768
2024
Q2 		$2.07M Sell
27,353
-4,097
-13% -$291K ﹤0.01% 2114
2024
Q1 		$2.36M Sell
31,450
-56,655
-64% -$4.51M ﹤0.01% 2433
2023
Q4 		$6.48M Buy
88,105
+36,862
+72% +$2.28M ﹤0.01% 1877
2023
Q3 		$2.36M Buy
51,243
+8,010
+19% +$356K ﹤0.01% 1787
2023
Q2 		$1.82M Buy
43,233
+11,710
+37% +$443K ﹤0.01% 1948
2023
Q1 		$822K Buy
31,523
+2,085
+7% +$61.7K ﹤0.01% 2884
2022
Q4 		$877K Buy
29,438
+28,721
+4,006% +$801K ﹤0.01% 2911
2022
Q3 		$14K Sell
717
-131
-15% -$2.19K ﹤0.01% 4185
2022
Q2 		$11K Sell
848
-2,128
-72% -$22.5K ﹤0.01% 4601
2022
Q1 		$41K Buy
+2,976
New +$43.2K ﹤0.01% 4194

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barclays's NUVL Position: Q1 2026 in Review

Barclays reduced its Nuvalent (NUVL) stake by 75% in Q1 2026, selling an estimated $9.63M and leaving 30,844 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Barclays first reported a position in NUVL in Q1 2022 and has held it in 17 quarters since. The position peaked at $12.6M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Barclays held 30,844 shares of Nuvalent worth $3.16M as of Q1 2026.
  • Barclays sold 94,484 Nuvalent shares in Q1 2026, an estimated $9.63M.
  • Nuvalent made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2094 holding.
  • Barclays first reported a position in Nuvalent in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Nuvalent position peaked at $12.6M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.